Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study

Dirk De Ruysscher*, Angela van Baardwijk, Rinus Wanders, Lizza E. Hendriks, Bart Reymen, Wouter van Empt, Michel C. Ollers, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne-Marie C. Dingemans

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)141-146
Number of pages6
JournalRadiotherapy and Oncology
Volume135
DOIs
Publication statusPublished - Jun 2019

Keywords

  • Non-small cell lung cancer
  • Individualized radiotherapy
  • Concurrent chemotherapy radiotherapy
  • Phase II trial
  • Prospective
  • NORMAL TISSUE CONSTRAINTS
  • LOCALLY ADVANCED HEAD
  • LONG-TERM SURVIVAL
  • RADIATION-THERAPY
  • PHASE-III
  • DOSE-ESCALATION
  • RADIOTHERAPY
  • CHEMOTHERAPY
  • TRIAL
  • CISPLATIN

Cite this